Chronic inflammation and allergy involve the activation of tissue-resident cells and, later on, the invasion of effector cells. We have previously shown that the loss of phosphoinositide 3-kinase (PI3K) γ impairs chemokine-dependent migration of neutrophils and macrophages both in vitro and in vivo. On the other hand, PI3Kγ is not required either during phagocytic processes or in the activation of bactericidal activities like granule secretion and particle-mediated respiratory burst in neutrophils. Tissue mast cells are key regulators in allergy and inflammation and release histamine upon clustering of their IgE receptors. We have demonstrated that murine mast cell responses are exacerbated in vitro and in vivo by autocrine signals, and require functional PI3Kγ . Adenosine, acting through the A 3 adenosine receptor, as well as other agonists of G αi -coupled receptors, transiently increased PtdIns(3,4,5)P 3 exclusively via PI3Kγ . PI3Kγ -derived PtdIns(3,4,5)P 3 was instrumental for initiation of a sustained influx of external Ca 2+ and degranulation. Mice that lacked PI3Kγ
Introduction
A functional and vigorous host defence system is vital to eliminate pathogens whenever encountered. This system involves humoral factors and immune cells that are part of the innate and acquired immune responses. While defence mobilization is normally well balanced and ceases after the destruction of the pathogen, it can get out of hand and result in damage of host tissue in chronic inflammatory and allergic conditions. The reason for these pathological states is often persistent accumulation and/or activation of immune cells in the tissue. Recently, some insight has been gained into how cells become activated and how they are recruited. Chemotactic factors, among them the prominent chemokines [1] , bind to heterotrimeric G-protein-coupled receptors (GPCRs) and thus initiate signalling cascades that govern directed movement or the release of inflammatory mediators. One of the pathways that is triggered consumes the plasma membrane lipid PtdIns(4,5)P 2 by the action of phospholipase C (PLC) β. PLCβ activation leads to the production of diacylglycerol and Ins(1,4,5)P 3 , culminating in the release of calcium from internal stores. The phosphoinositide 3-kinase (PI3K) family, on the other hand, utilizes PtdIns(4,5)P 2 to generate PtdIns(3,4,5)P 3 , which composes a targeting site for effector proteins with pleckstrin homology (PH) domains, Phox homology (PX) domains and epsin N-terminal homology (ENTH) domains [2] [3] [4] [5] [6] .
Ways to activate PI3Ks
PtdIns(3,4,5)P 3 was, in fact, first identified in Nformylmethionyl-leucylphenylalanine (fMLP)-stimulated neutrophils [7] , and its transient accumulation correlated with rapid neutrophil responses, such as actin polymerization, polarization, granule release and the respiratory burst [8] . The first PI3K to be cloned, however, consisted of a heterodimeric complex of a regulatory p85 and a 110 kDa catalytic subunit (p110α; reviewed in [9] ). The adaptor protein is encoded by three individual genes (α, β and γ ) and gives rise to multiple splice variants (p85α, β and p55α, β, γ ), which all contain two Src homology 2 (SH2) domains that bind to phosphorylated Tyr-Xaa-Xaa-Met motifs on protein tyrosine kinase receptors or their adaptor proteins. There are three catalytic isoforms associated with p85-like proteins, p110α, β and δ, which are now classified as class IA PI3Ks. The only member of the class IB PI3Ks, named PI3Kγ , was found to be activated by βγ subunits of trimeric G-proteins [10, 11] and was isolated from granulocytes that were tightly bound to a p101 protein [11, 12] . Although this suggests that PI3Kγ relays GPCR signalling, it has also been reported that also p85-associated class IA isoforms can be activated The class IB PI3Kγ is associated with the adaptor molecule p101 and both interact with the βγ subunits of heterotrimeric G-proteins, which are dissociated from G αi when the αβγ complex interacts with an engaged GPCR. The PtdIns(3,4,5)P 3 (PIP 3 ) that is produced by PI3Kγ co-operates with protein tyrosine kinases (PTKs) to activate guanine nucleotide exchange factors (GEFs) that exchange GTP for GDP on small Rho-family GTPases. These GTPases, in particular Rac2 and Cdc42, are required to trigger cytoskeletal rearrangements and cell motility. Class IA PI3Ks are associated with p85-like regulatory subunits which are encoded by three individual genes and come in various splice variants (reviewed in [9] by GPCR stimulation in vivo and by βγ G-protein subunits in vitro [13] [14] [15] [16] (Figure 1 ). Pharmacological inhibition of PI3Ks by wortmannin [17] or LY294002 [18] were useful to demonstrate the involvement of PI3Ks in a variety of leucocyte responses, but could not be used to discriminate between distinct PI3K isoforms (reviewed in [19] ). Neutralizing, isoform-specific antibodies were first used to demonstrate that PI3Kγ is required for natural killer cell migration to monocyte chemoattractant protein (MCP-1), the chemotactic cytokine RANTES, IP-10 (interferon-α-inducible protein-10), SDF-1 (stromal-cellderived factor 1) and lymphotactin [20] . In the macrophage cell line Bac1.2F5, migrating towards colony-stimulating factor 1 (CSF-1), only p110β and δ, but not p110α, were essential for the chemotactic process [21] .
PI3Kγ couples to GPCRs and directs cell migration
The coupling of GPCRs to PI3K isoforms in haematopoietic cells was finally determined in mice that lacked PI3Kγ : neutrophils and macrophages derived from mutant animals failed to produce PtdIns(3,4,5)P 3 in response to stimulation with various chemotactic substances, whereas the signalling through protein tyrosine kinase-coupled receptors to class IA PI3Ks was intact [22] [23] [24] . In agreement, PtdIns(3,4,5)P 3 -mediated phosphorylation of protein kinase B (PKB/Akt) was not initiated by GPCR ligands in PI3Kγ -null cells (PKB/Akt activation is reviewed in [25, 26] ). Taken together, these results demonstrated that, at least in resting haematopoietic cells, PI3Kγ is the sole PI3K isoform that is activated by GPCRs in vivo.
The use of PI3K inhibitors to elucidate the role of the lipid kinases in leucocyte migration yielded controversial results: in some laboratories, wortmannin terminated the chemotaxis of neutrophils towards fMLP or interleukin-8 (IL-8) [27, 28] , whereas the response was observed to be intact by others, even in the presence of inhibitors [29, 30] . When murine bone-marrow-derived neutrophils and peritoneal macrophages from wild-type and PI3Kγ
−/− mice were tested under similar conditions, a reduced, but not completely abrogated, performance in chemotaxis and adherence assays was observed in vitro [22] [23] [24] . All the same, this translated into a drastic impairment of neutrophil infiltration driven by IL-8 into tissues [22] . Recent data suggest that PI3Kγ is mostly involved in the pathfinding process and not in the generation of mechanical force for motility, as random migration was not impaired in cells that lacked PI3Kγ [31] . In parallel, it has been shown that chemotactic substances induce the formation of steep PtdIns(3,4,5)P 3 gradients, which depend on positive feedback loops involving Rho GTPases [32, 33] . PI3Kγ has thus been dubbed 'the neutrophil's compass' [34] .
Loss of PI3Kγ modulates the inflammatory process
Although PI3Kγ is highly expressed in leucocytes, its loss seems not to interfere with haematopoiesis. Cell numbers detected in the blood, however, are affected, as apparent neutrophil numbers are doubled, while lymphocyte counts are decreased in mutant mice [22, 23] . Lack of lymphocyte responsiveness to chemokines that are constitutively expressed in the thymus, and subsequently reduced thymocyte survival and T-cell activation, could explain the decrease in circulating lymphocyte levels [23] .
PI3Kγ -null macrophages and neutrophils showed an impaired infiltration into the inflamed peritoneal cavity and consequently could not clear infections as efficiently as wildtype controls [22] . This is similar to that of phenotypes found in mice that lack β 2 integrins [35] , human patients with leucocyte adhesion deficiency (LAD) syndrome [36] and mice lacking the small GTPase Rac2. In contrast with Rac1, Rac2 is specifically expressed in haematopoietic cells, and its loss increases circulating neutrophils and abrogates normal neutrophil chemotaxis in humans and mice [37, 38] . Rac is assumed to be a downstream target of PI3K, and the findings reported above suggest that these proteins control key steps in in vivo migration. The fact that phagocytic and secretory responses, and the activation of the neutrophil NADPH oxidase by particulate stimuli are sensitive to PI3K inhibitors [17, 39] , but are still intact in PI3Kγ -null cells, shows that p85-associated PI3Ks are downstream of complement, immunoglobulin and cytokine receptors and act when a cell reaches its target.
Therapeutic inhibition of PI3Kγ could thus probably interfere with the accumulation of inflammatory cells at the site of chronic inflammation. Granulocytes, in particular macrophages, cause tissue damage in diverse pathological states, e.g. arthritis, arteriosclerosis and multiple sclerosis.
Loss of PI3Kγ modulates anaphylactic and allergic responses
Inflammatory and allergic responses are initiated by the activation of tissue-resident cells, such as macrophages and mast cells. Because mast cells display high-affinity IgE receptors (FcεRIs) on their surface, they are primary effector cells in atopy and acquired immunity. In parallel, they integrate signals derived from complement activation (C5a and C3a), inflammation and ischaemia (adenosine and chemokines), which act through GPCRs (reviewed in [40] ). Antigen-IgE complex interactions with the α chain of the FcεRI receptor clusters the two associated γ chains and an optional β chain. This triggers the activation of the protein tyrosine kinase Lyn and recruitment of Syk, resulting in the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs). These can serve as docking sites for the SH2 domains in the class IA PI3K adaptor subunits. The resulting PtdIns(3,4,5)P 3 formation is essential to trigger the activation of Bruton's tyrosine kinase (Btk) and subsequently PLCγ . Taken together, these events lead to the opening of plasma membrane calcium channels and granule release. With some delay, prostaglandins, leukotrienes and cytokines are discharged as well. Activation of the mast cells is, however, counteracted by the SH2-containing inositol 5 -phosphatase (SHIP) [41, 42, 43] (Figure 2) . Although the role of class IA PI3Ks is clear in this scheme, the downstream events of GPCR engagement in mast cells remain to be further elucidated. That the latter enforce antigen-mediated allergic responses is evident in atopic patients who display bronchial hyperreactivity when they inhale adenosine. Smooth muscle contraction, mucus secretion, increase in vascular permeability and inflammation at a later stage are the systemic consequences of mast cell activation [44] .
Surprisingly, PI3Kγ -null bone-marrow-derived mast cells (BMMCs) were less sensitive to antigen-IgE stimulation as compared to wild-type mast cells. Release of histaminecontaining granules (monitored by the liberation of β-hexosaminidase from the same granules) and the rise in intracellular calcium concentration were both diminished by the loss of PI3Kγ . Several lines of evidence pointed to the existence of an autocrine activation loop that facilitated mast cell activation (Figure 3) . The application of adenosine deaminase (degrading adenosine to inosine) finally eliminated >65% of the PI3Kγ -dependent response, indicating that adenosine released by mast cells acted on intrinsic adenosine receptors (ARs). Bordetella pertussis toxin (PTx) had the same effect, which suggests that the engaged GPCR is Gαi-coupled. The fact that adenosine could be replaced by a A 3 AR-selective agonist [N 6 -(3-iodobenzyl)-adenosine-5 -N-methylcarboxamide; IB-MECA] suggested that the A 3 AR was triggering the major part of the PI3Kγ -dependent signal [45] . Mast cells derived from mice lacking the A 3 AR were shown previously to be insensitive to adenosine stimulation [46, 47] .
Whereas adenosine initiated a prominent, but transient rise of PtdIns(3,4,5)P 3 in wild-type BMMCs, this was absent in cells devoid of PI3Kγ . The long lasting increase of PI3K 
Clustering of FcεRIs by IgE-antigen complexes leads to the phosphorylation of immunoreceptor tyrosine-based activation motifs (ITAMs) which recruit Syk and p85/p110 PI3Ks. PtdIns(3,4,5)P 3 , which is produced by class IA PI3Ks, is degraded by SHIP, releasing PtdIns(3,4)P 2 . PtdIns(3,4,5)P 3 is needed to activate Btk (Bruton's tyrosine kinase). A pulse of PtdIns(3,4,5)P 3
can be provided by the GPCR-mediated activation of PI3Kγ . Once Btk is activated, it phosphorylates PLCγ , and the latter cleaves PtdIns(4,5)P 2 to produce diacylglycerol and Ins(1,4,5)P 3 . This leads to the release of calcium from internal stores, and the empty stores then trigger the opening of store-operated calcium channels (SOCCs) in the plasma membrane. Alternatively, PtdIns(3,4,5)P 3 acts on SOCCs directly [54] .
activity induced by IgE-antigen complexes, on the other hand, remained intact in both genotypes. The work described above and data shown in [45] illustrate that the A 3 AR relays on PI3Kγ to produce a pulse of PtdIns(3,4,5)P 3 . The lipid can then co-operate with the signalling of the FcεRI receptor, where SHIP eliminates PtdIns(3,4,5)P 3 derived from class IA PI3Ks. Together, the FcεRI-mediated activation of protein tyrosine kinases and the PtdIns(3,4,5)P 3 produced by PI3Kγ can circumvent the down-regulation mediated by SHIP. That this is physiologically relevant could be demonstrated in a model of passive systemic anaphylaxis. Whereas wildtype mice developed a dramatic increase in vasopermeability after the injection of IgE and an experimental allergen (derivatized BSA), PI3Kγ -null animals were protected [45] . Interestingly, A 3 AR null mice were still sensitive to a passive systemic anaphylactic challenge [47] . The distinct phenotype of the PI3Kγ -null and A 3 AR-null animals can be explained when it is assumed that other GPCR agonists play a role in mast cell activation in vivo. This view was confirmed by the observation that chemokines [e.g. MIP-1α, RANTES, ATP, ADP, LPA (lysophosphatidic acid)]
and more, could co-operate with IgE-antigen complexes in mast cell activation. Moreover, it has been shown by others that mast cells can produce chemokines themselves [48, 49] .
PI3Kγ -a drug target?
Chemokines are considered to be major players in the inflammatory process and cell migration. It is assumed that chemokine antagonists would block cell migration and alleviate chronic disease [50] [51] [52] . Such a strategy could potentially target individual cell populations and minimize side effects, but might fall short because of highly redundant signals released under various inflammatory conditions. Inhibition of PI3Kγ could eventually block the relay of GPCR signals at a point further down the line. The fact that PI3Kγ -null mice are viable and fertile suggests that humans might also tolerate inhibition of this PI3K isoform. A high degree of selectivity would be advantageous as, at present, non-isoform-specific PI3K inhibitors display too high a toxicity. In parallel with efforts to develop selective inhibitors, the exact downstream targets of PI3Kγ need to be elucidated further. The pathways of importance appear to vary between cell types and little is known about how PI3Kγ -derived PtdIns(3,4,5)P 3 co-operates with other pathways in space and time. Once this is achieved, PI3Kγ might indeed 'burst with potential' [53] .
